← Eichor
Study identifier: NCT06854367 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Accelerated vs. Conventional Theta Burst Stimulation for Late-life Depression

Condition: Late Life Depression (LLD) · Depression - Major Depressive Disorder · Depressive Disorder, Treatment-Resistant  ·  Sponsor: Centre for Addiction and Mental Health

PhaseNA
Planned participants280
Who can joinAll sexes, 60 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this trial is to compare the treatment efficacy (improvement in depressive symptoms) of accelerated TBS protocol (where participants receive multiple TBS treatments daily) to conventional TBS protocol (where participants receive a single TBS treatment daily) in late life depression. In addition, the study also aims to determine if specific patterns of stimulation are more or less effective. To do this, all participants will receive active treatments, but some of the participants in this study will receive accelerated TBS and some will receive once daily TBS.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (2)

Sunnybrook Health Sciences CentreToronto, Ontario, CanadaRecruiting
Centre for Addiction and Mental HealhToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06854367